Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 694

1.

Adjunctive granisetron therapy in patients with sepsis or septic shock (GRANTISS): Study protocol for a randomized controlled trial.

Guan J, Guo Y, Chang P, Gan J, Zhou J, Wang H, Cen Z, Tang Y, Liu Z, Chen P.

Medicine (Baltimore). 2019 Sep;98(39):e17354. doi: 10.1097/MD.0000000000017354.

2.

[Effect of intravenous granisetron combined and acupuncture point injection at PC6(Neiguan) with 0.9% sodium chlorideon postoperative nausea and vomiting after gynecological laparoscopy].

Yu Y, Fan H, Cheng Y, Sun JL.

Zhonghua Yi Xue Za Zhi. 2019 Sep 3;99(33):2606-2610. doi: 10.3760/cma.j.issn.0376-2491.2019.33.010. Chinese.

PMID:
31510721
3.

Granisetron reduces the need for uterotonics but not sympathomimetics during cesarean delivery.

Raimann FJ, Baldauf HP, Louwen F, Jennewein L, Fischer D, Zacharowski K, Weber CF.

Int J Gynaecol Obstet. 2019 Jun;145(3):361-366. doi: 10.1002/ijgo.12819. Epub 2019 Apr 15.

PMID:
30932170
4.

Palonosetron on Days 1 and 5 Versus Granisetron Daily (Days 1-5) in Germ Cell Tumour Therapy.

Shimura Y, Izumi K, Itai S, Iwamoto H, Yaegashi H, Suga Y, Shimada T, Mizokami A, Sai Y.

In Vivo. 2019 Mar-Apr;33(2):643-647. doi: 10.21873/invivo.11522.

5.

Efficacy of Palonosetron as Antiemetic Prophylaxis for Post Operative Patients.

Hossain MM, Begum M, Hossain M, Chowdhury MG, Begum R, Ahamed S, Shuvo FR.

Mymensingh Med J. 2019 Jan;28(1):222-229.

PMID:
30755573
6.
7.

Granisetron protects polymicrobial sepsis-induced acute lung injury in mice.

Wang J, Gong S, Wang F, Niu M, Wei G, He Z, Gu T, Jiang Y, Liu A, Chen P.

Biochem Biophys Res Commun. 2019 Jan 22;508(4):1004-1010. doi: 10.1016/j.bbrc.2018.12.031. Epub 2018 Dec 11.

8.

Hydration requirements in patients receiving highly emetogenic chemotherapy.

Erickson R, Nebughr N, Mosier MC, Nibley W.

Future Oncol. 2019 Mar;15(7):753-761. doi: 10.2217/fon-2018-0787. Epub 2018 Nov 30.

9.

Pharmacokinetics and safety of transdermal and oral granisetron in healthy Chinese subjects: An open-label, randomized, crossover study‚Ä©.

Chen R, Chen X, Wang H, Zhong W, Oh ES, Park MS, Kumagai Y, Zhou L, Nagahama F, Hu P.

Int J Clin Pharmacol Ther. 2019 Jan;57(1):24-31. doi: 10.5414/CP203327.

PMID:
30336808
10.

Involvement of the Hypothalamic Glutamatergic System in the Development of Radiation-Induced Pica in Rats.

Yamamoto K, Yamatodani A.

Radiat Res. 2018 Dec;190(6):645-649. doi: 10.1667/RR15064.1. Epub 2018 Sep 12.

PMID:
30207505
11.

Risk factors associated with chemotherapy-induced nausea and vomiting in the triplet antiemetic regimen including palonosetron or granisetron for cisplatin-based chemotherapy: analysis of a randomized, double-blind controlled trial.

Tsuji D, Suzuki K, Kawasaki Y, Goto K, Matsui R, Seki N, Hashimoto H, Hama T, Yamanaka T, Yamamoto N, Itoh K.

Support Care Cancer. 2019 Mar;27(3):1139-1147. doi: 10.1007/s00520-018-4403-y. Epub 2018 Aug 10.

PMID:
30094732
12.

Impact of adjuvant lorazepam with granisetron on chemotherapy-induced nausea and vomiting in pediatric patients with acute lymphoblastic leukemia.

Ono A, Kishimoto K, Hasegawa D, Goldman RD, Kosaka Y.

Support Care Cancer. 2019 Mar;27(3):895-899. doi: 10.1007/s00520-018-4377-9. Epub 2018 Jul 31.

PMID:
30066198
13.

A phase 2 study of fosaprepitant combined with high-dose dexamethasone for Japanese cancer patients receiving highly emetogenic chemotherapy.

Kumagai H, Kusaba H, Yamanaka T, Nio K, Inadomi K, Takayoshi K, Ito M, Tamura S, Makiyama A, Makiyama C, Hirano G, Shibata Y, Shirakawa T, Mitsugi K, Ariyama H, Esaki T, Akashi K, Baba E.

Medicine (Baltimore). 2018 Jun;97(25):e11042. doi: 10.1097/MD.0000000000011042.

14.

Synthesis, Characterization and Biocompatibility of N-palmitoyl L-alanine-based Organogels as Sustained Implants of Granisetron and Evaluation of thier Antiemetic Effect.

El-Nassan HB, ElMeshad AN, Wadie W, Sayed RH.

Pharm Res. 2018 May 29;35(8):149. doi: 10.1007/s11095-018-2433-2.

PMID:
29845459
15.

Comparison of antiemetic effects of granisetron and palonosetron in patients receiving bendamustine-based chemotherapy.

Uchida M, Nakamura T, Makihara Y, Suetsugu K, Ikesue H, Mori Y, Kato K, Shiratsuchi M, Hosohata K, Miyamoto T, Akashi K.

Pharmazie. 2018 May 1;73(5):304-308. doi: 10.1691/ph.2018.7948.

PMID:
29724299
16.

Effects of a histamine H4 receptor antagonist on cisplatin-induced anorexia in mice.

Yamamoto K, Okui R, Yamatodani A.

Neurosci Lett. 2018 May 29;676:103-107. doi: 10.1016/j.neulet.2018.04.019. Epub 2018 Apr 12.

PMID:
29655943
17.

Compatibility and Stability of Nab-Paclitaxel in Combination with Other Drugs.

Mizuta N, Nakagawa T, Yamamoto K, Nishioka T, Kume M, Makimoto H, Yano I, Minami H, Hirai M.

Kobe J Med Sci. 2017 Jul 20;63(1):E9-E16.

18.

Hydration requirements with emetogenic chemotherapy: granisetron extended-release subcutaneous versus palonosetron.

Vacirca J, Caruana D, Calcanes G, Mosier M, Boccia R, McBride A.

Future Oncol. 2018 Jun;14(14):1387-1396. doi: 10.2217/fon-2017-0720. Epub 2018 Feb 9.

19.

Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Granisetron Hydrochloride.

Wu G, Powers D, Yeung S, Chen F, Neelon K.

Int J Pharm Compd. 2018 Jan-Feb;22(1):86-94.

PMID:
29385389
20.

[Electrothermal acupuncture in the prevention and treatment of chemotherapy-induced nausea and vomiting:a randomized controlled trial].

Lu D, Lu D, Bai D, He S, Wang F, Gao Y, Du Y, Wang N, Jiang Z, Wang Z, Zhu S.

Zhongguo Zhen Jiu. 2017 Apr 12;37(4):355-359. doi: 10.13703/j.0255-2930.2017.04.003. Chinese.

PMID:
29231584

Supplemental Content

Loading ...
Support Center